Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000056

EVP, Chief Scientific Officer sold 6,752 shares at $32.90 ($222,114)

  • EVP, Chief Scientific Officer acquired 18,011 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BENNETT C FRANK · EVP, Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-15 Exercise or conversion : show line 1 in the form +18,011 97,618 D
2025-01-16 Sale : show line 2 in the form −6,752 $32.90 $222,114 90,866 D
Open-market sales · 6,752 sh · avg $32.90 · $222,114

Table II: Derivative

3 lines
Date Transaction Shares Exercise Underlying Owned after D/I
2025-01-15 Grant or award : show line 3 in the form Performance Restricted Stock Units +22,000 $0.00 22,000 63,482 D
2025-01-15 Grant or award : show line 4 in the form Restricted Stock Unit +33,000 $0.00 33,000 56,500 D
2025-01-15 Exercise or conversion : show line 5 in the form Restricted Stock Unit −18,011 $0.00 18,011 38,489 D
Loading xslF345X05/edgardoc.xml…